165 related articles for article (PubMed ID: 26909392)
1. BDNF as a biomarker in the course and treatment of schizophrenia.
Libman-Sokołowska M; Drozdowicz E; Nasierowski T
Psychiatr Pol; 2015; 49(6):1149-58. PubMed ID: 26909392
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients.
Ikegame T; Bundo M; Sunaga F; Asai T; Nishimura F; Yoshikawa A; Kawamura Y; Hibino H; Tochigi M; Kakiuchi C; Sasaki T; Kato T; Kasai K; Iwamoto K
Neurosci Res; 2013 Dec; 77(4):208-14. PubMed ID: 23973796
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation of BDNF Gene in Schizophrenia.
Çöpoğlu ÜS; Igci M; Bozgeyik E; Kokaçya MH; İğci YZ; Dokuyucu R; Ari M; Savaş HA
Med Sci Monit; 2016 Feb; 22():397-402. PubMed ID: 26851233
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia.
Kordi-Tamandani DM; Sahranavard R; Torkamanzehi A
Mol Biol Rep; 2012 Dec; 39(12):10889-93. PubMed ID: 23065263
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of the BDNF gene and its relevance to psychiatric disorders.
Ikegame T; Bundo M; Murata Y; Kasai K; Kato T; Iwamoto K
J Hum Genet; 2013 Jul; 58(7):434-8. PubMed ID: 23739121
[TBL] [Abstract][Full Text] [Related]
6. BDNF DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysis.
Zheleznyakova GY; Cao H; Schiöth HB
Behav Brain Funct; 2016 Jun; 12(1):17. PubMed ID: 27267954
[TBL] [Abstract][Full Text] [Related]
7. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
[TBL] [Abstract][Full Text] [Related]
8. Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.
Huang TL; Lin CC; Chen RF; Lee CT
Psychiatry Res; 2016 Sep; 243():207-9. PubMed ID: 27419650
[TBL] [Abstract][Full Text] [Related]
9. Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia.
Lee J; Nurjono M; Lee TS
J Nerv Ment Dis; 2016 Aug; 204(8):636-9. PubMed ID: 27479612
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
Zakharyan R; Boyajyan A
Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects.
Keller S; Errico F; Zarrilli F; Florio E; Punzo D; Mansueto S; Angrisano T; Pero R; Lembo F; Castaldo G; Usiello A; Chiariotti L
Psychiatry Res; 2014 Dec; 220(3):1147-50. PubMed ID: 25219617
[TBL] [Abstract][Full Text] [Related]
12. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
[TBL] [Abstract][Full Text] [Related]
13. Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?
Arabska J; Margulska A; Strzelecki D; Wysokiński A
Nord J Psychiatry; 2019 Nov; 73(8):515-521. PubMed ID: 31464540
[No Abstract] [Full Text] [Related]
14. Expression and methylation of BDNF in the human brain in schizophrenia.
Cheah SY; McLeay R; Wockner LF; Lawford BR; Young RM; Morris CP; Voisey J
World J Biol Psychiatry; 2017 Aug; 18(5):392-400. PubMed ID: 27712141
[TBL] [Abstract][Full Text] [Related]
15. BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial.
Penadés R; López-Vílchez I; Catalán R; Arias B; González-Rodríguez A; García-Rizo C; Masana G; Ruíz V; Mezquida G; Bernardo M
Schizophr Res; 2018 Jul; 197():458-464. PubMed ID: 29274733
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia.
Li C; Tao H; Yang X; Zhang X; Liu Y; Tang Y; Tang A
Int J Med Sci; 2018; 15(9):900-906. PubMed ID: 30008602
[TBL] [Abstract][Full Text] [Related]
17. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
[TBL] [Abstract][Full Text] [Related]
19. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.
Na KS; Won E; Kang J; Chang HS; Yoon HK; Tae WS; Kim YK; Lee MS; Joe SH; Kim H; Ham BJ
Sci Rep; 2016 Feb; 6():21089. PubMed ID: 26876488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]